Bromide

Bromide

SCHEMBL2336705

Cc1ccc2c(ccc[n+]2Cc2ccccc2)c1.[Br-]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 5/20 0.65
KDM4E B2RXH2 7/20 0.60
KMT2A Q03164 4/20 0.60
BCHE P06276 3/20 0.59
LMNA P02545 2/20 0.58
RAB9A P51151 3/20 0.55
ALDH1A1 P00352 2/20 0.55
HPGD P15428 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NPC1 O15118 2/20 0.55
MITF O75030 1/20 0.55
GLA P06280 1/20 0.55
GAA P10253 1/20 0.55
HTT P42858 1/20 0.55
MAPT P10636 1/20 0.55
MEN1 O00255 3/20 0.46
POLB P06746 1/20 0.43
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25334051 0.98 ACHE (0.67) ACHEKDM4EKMT2ABCHELMNA
Hydrochloric Acid SCHEMBL25330408 0.97 ACHE (0.65) ACHEKDM4EKMT2ABCHELMNA
Bromide SCHEMBL1069897 0.81 ACHE (0.79) ACHEKDM4EKMT2ABCHERAB9A
Bromide SCHEMBL2566518 0.81 ACHE (0.61) ACHEKDM4EKMT2ABCHELMNA
Bromide SCHEMBL2340311 0.81 ACHE (0.97) ACHEKDM4EKMT2ABCHELMNA
SCHEMBL29729955 0.79 ACHE (0.76) ACHEKDM4EKMT2ABCHERAB9A
SCHEMBL1127587 0.79 ACHE (0.76) ACHEKDM4EKMT2ABCHERAB9A
SCHEMBL25356547 0.79 ACHE (0.62) ACHEKDM4EKMT2ABCHELMNA
Hydrochloric Acid SCHEMBL1071121 0.78 ACHE (0.73) ACHEKDM4EKMT2ABCHERAB9A
Hydrochloric Acid SCHEMBL29943765 0.78 ACHE (0.73) ACHEKDM4EKMT2ABCHERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8569502-B2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids Geddes, Chris (US) 2013-10-29 US disclosed
US-20130210158-A1 QUATERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS GEDDES, CHRIS, DR. 2013-08-15 US disclosed
US-8338602-B2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) 2012-12-25 US disclosed
EP-1671118-B1 CYANIDE SENSING COMPOUNDS AND USES THEREOF UNIV MARYLAND (US) 2011-11-02 EP disclosed
EP-1644330-B1 QUATERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS UNIV MARYLAND (US) 2011-08-17 EP disclosed
US-20100297016-A1 QUARTERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS GEDDES, CHRIS, DR. 2010-11-25 US disclosed
US-7732215-B2 Cyanide sensing compounds and uses thereof UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2010-06-08 US disclosed
US-7718804-B2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2010-05-18 US disclosed
EP-1644330-A4 QUATERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS UNIV MARYLAND BIOTECH INST (US) 2009-06-03 EP disclosed
US-20080096281-A1 Cyanide Sensing Compounds and Uses Thereof GEDDES, CHRIS, DR. 2008-04-24 US disclosed
US-20070020182-A1 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids GEDDES, CHRIS, DR. 2007-01-25 US disclosed
EP-1671118-A2 CYANIDE SENSING COMPOUNDS AND USES THEREOF University of Maryland Biotechnology Institute (US) 2006-06-21 EP disclosed
EP-1644330-A2 QUATERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2006-04-12 EP disclosed
WO-2005029033-A2 CYANIDE SENSING COMPOUNDS AND USES THEREOF UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2005-03-31 WO disclosed
WO-2005000109-A2 QUATERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2005-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297016-A1 QUARTERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS SLC5A1, NISCH, SLC5A2 ACHE 1414/4885KDM4E 4323/4885KMT2A 4551/4885
US-20130210158-A1 QUATERNARY NITROGEN HETEROCYCLIC COMPOUNDS FOR DETECTING AQUEOUS MONOSACCHARIDES IN PHYSIOLOGICAL FLUIDS SLC5A1, NISCH, SLC5A2 ACHE 1048/4885KDM4E 4482/4885KMT2A 4298/4885
US-20070020182-A1 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids SLC5A1, NISCH, SLC5A2 ACHE 1048/4885KDM4E 4482/4885KMT2A 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.